U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07535099) titled 'Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects' on March 29.
Brief Summary: This is a Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ICP-538 in Healthy Subjects
Study Start Date: March 13
Study Type: INTERVENTIONAL
Condition:
Health Services Research
Intervention:
DRUG: ICP-538 Tablets
ICP-538 will be administered as tablet
DRUG: ICP-538 placebo Tablets
Matching placebo will be administered as tablet
Recruitment Status: RECRUITING
Sponsor...